NRXBF (NurExone Biologic) Purchase Of Investment : $0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is NurExone Biologic Purchase Of Investment?

NurExone Biologic's purchase of investment for the three months ended in Sep. 2024 was $0.00 Mil. It means NurExone Biologic spent $0.00 Mil on purchasing investments. NurExone Biologic's purchase of investment for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2024 ), NurExone Biologic spent the same money on purchasing investments in Sep. 2024 ($0.00 Mil).

NurExone Biologic Purchase Of Investment Historical Data

The historical data trend for NurExone Biologic's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NurExone Biologic Purchase Of Investment Chart

NurExone Biologic Annual Data

Trend

Dec21

Dec22

Dec23

Purchase Of Investment

NurExone Biologic Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Purchase Of Investment	Get a 7-Day Free Trial									-	-	-	-	-

NurExone Biologic Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

NurExone Biologic Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of NurExone Biologic's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

NurExone Biologic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (OTCPK:NRXBF) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

J90:Germany NRX:Canada

Address

1 Adelaide St. East, Suite 801, Toronto, ON, CAN, M5C 2V9

Website

https://www.nurexone.com

NurExone Biologic Inc is a company that focuses on developing innovative, biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the global biopharmaceutical industry for other diseases and indications.